Boston Trust Walden’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-375,070
Closed -$15.3M 386
2021
Q1
$15.3M Sell
375,070
-3,097
-0.8% -$126K 0.15% 189
2020
Q4
$17.1M Buy
378,167
+2,669
+0.7% +$121K 0.18% 162
2020
Q3
$13.3M Buy
375,498
+17,016
+5% +$602K 0.17% 171
2020
Q2
$13.5M Buy
358,482
+32,163
+10% +$1.21M 0.18% 170
2020
Q1
$9.43M Buy
326,319
+106,501
+48% +$3.08M 0.15% 183
2019
Q4
$11.4M Sell
219,818
-151,778
-41% -$7.87M 0.13% 200
2019
Q3
$20.4M Buy
371,596
+406
+0.1% +$22.3K 0.26% 117
2019
Q2
$15.1M Buy
371,190
+107,675
+41% +$4.37M 0.2% 150
2019
Q1
$7.97M Buy
263,515
+13,978
+6% +$423K 0.11% 205
2018
Q4
$8.39M Buy
249,537
+33,406
+15% +$1.12M 0.13% 190
2018
Q3
$9.12M Sell
216,131
-11,942
-5% -$504K 0.13% 196
2018
Q2
$7.3M Sell
228,073
-5,662
-2% -$181K 0.11% 209
2018
Q1
$11.6M Sell
233,735
-16,413
-7% -$816K 0.18% 165
2017
Q4
$13.5M Sell
250,148
-7,130
-3% -$384K 0.2% 148
2017
Q3
$14.9M Sell
257,278
-4,714
-2% -$273K 0.23% 131
2017
Q2
$12.9M Sell
261,992
-79,257
-23% -$3.91M 0.21% 141
2017
Q1
$14.8M Sell
341,249
-43,773
-11% -$1.9M 0.23% 143
2016
Q4
$18.9M Sell
385,022
-15,622
-4% -$765K 0.3% 130
2016
Q3
$19.2M Sell
400,644
-85,750
-18% -$4.1M 0.32% 125
2016
Q2
$26.1M Sell
486,394
-7,386
-1% -$396K 0.45% 79
2016
Q1
$22.1M Sell
493,780
-5,757
-1% -$257K 0.38% 101
2015
Q4
$19.1M Sell
499,537
-187,999
-27% -$7.17M 0.35% 111
2015
Q3
$21.9M Buy
687,536
+5,336
+0.8% +$170K 0.37% 111
2015
Q2
$22.5M Sell
682,200
-17,362
-2% -$573K 0.34% 130
2015
Q1
$28.8M Sell
699,562
-14,385
-2% -$592K 0.43% 105
2014
Q4
$29.1M Buy
713,947
+315,733
+79% +$12.9M 0.43% 106
2014
Q3
$14.6M Buy
+398,214
New +$14.6M 0.23% 158